Approved indications:

• Treatment and prevention of osteoporosis in postmenopausal women at risk for fracture.
• Treatment of osteoporosis in men to increase bone mass.
• Treatment and prevention of glucocorticoid-induced osteoporosis in men and women receiving long-term systemic corticosteroids.
• Treatment of Paget’s disease of bone in adults.

Off-label uses (evidence):

• Management of osteoporosis or low bone density in certain younger adults with secondary causes of bone loss (e.g., some endocrine disorders), based on clinical judgment and extrapolation from adult data.
• Supportive use in some cancer-related bone loss settings when other bisphosphonates or bone drugs are not suitable, though IV agents are usually preferred.

Efficacy expectations:

• Bone mineral density often begins to improve within 3–6 months, with meaningful fracture-risk reduction typically seen over 1–3 years of consistent use.
• Alendronate lowers the risk of vertebral, hip, and nonvertebral fractures in high-risk patients when combined with adequate calcium and vitamin D.
• Its effectiveness in improving bone density and reducing fractures is comparable to other oral bisphosphonates and is considered a first-line option for many people with osteoporosis.

Typical adult dosing:

• Postmenopausal osteoporosis treatment: 70 mg by mouth once weekly or 10 mg once daily.
• Postmenopausal osteoporosis prevention: 35 mg once weekly or 5 mg once daily.
• Osteoporosis in men: 70 mg once weekly or 10 mg once daily.
• Glucocorticoid-induced osteoporosis: usually 5 mg once daily (10 mg once daily in some postmenopausal women not taking estrogen).
• Paget’s disease of bone: 40 mg once daily for 6 months, with reassessment afterwards.

How to take it:

• Take the tablet first thing in the morning with a full glass (6–8 oz) of plain water only; do not use mineral water, coffee, juice, or other drinks.
• Swallow whole; do not chew or suck the tablet.
• Do not eat, drink anything else, or take other medicines, vitamins, or supplements for at least 30 minutes afterward.
• Remain fully upright (sitting or standing) for at least 30 minutes after the dose to reduce the risk of esophagus irritation.

Special instructions: Take it on the same day each week if using weekly dosing; ensure adequate calcium and vitamin D intake unless contraindicated; a healthcare provider may reevaluate the need for ongoing therapy after about 3–5 years, especially in lower-risk patients.

Missed dose guidance: If you miss a weekly dose, take it the next morning after you remember, then return to your usual scheduled day the following week; never take two doses on the same day. If you miss a daily dose, skip it if it is almost time for the next one—do not double up.

Overdose: Taking too much alendronate can cause significant stomach upset, heartburn, and low blood calcium; do not induce vomiting, drink a full glass of milk or take an antacid if able, and seek urgent medical or poison-control advice immediately.

Common side effects:

• Stomach or digestive symptoms such as abdominal pain, heartburn, nausea, constipation, diarrhea, or gas are relatively common, especially if taken incorrectly (with food or without enough water).
• Muscle, bone, or joint aches can occur and are usually mild to moderate but occasionally can be severe.
• Mild, temporary drops in blood calcium may occur, particularly in people with low vitamin D or calcium intake.

Serious or rare adverse effects (seek immediate care):

• Severe chest pain, painful or difficult swallowing, new or worsening heartburn, or black/tarry stools (possible esophagus or stomach injury).
• New or unusual thigh, hip, or groin pain, which may be a warning sign of an atypical femur fracture with long-term use.
• Jaw pain, swelling, or poor healing after dental work, which could signal osteonecrosis of the jaw (rare).
• Severe bone, joint, or muscle pain; allergic reactions (rash, swelling, trouble breathing); or eye pain/redness with vision changes.

Warnings and precautions:

• Do not use if you have low blood calcium, serious esophageal problems that delay emptying, or cannot sit or stand upright for at least 30 minutes after taking the dose.
• Use is not recommended in people with severe kidney impairment (creatinine clearance <35 mL/min).
• Safety in children has not been established; routine use in pediatrics is not recommended.
• Generally avoided in pregnancy and breastfeeding unless the potential benefit clearly outweighs risks, as the drug can stay in bone for years.

Overall safety compared with similar drugs: Alendronate has a long safety record; its main concerns are gastrointestinal irritation and very rare long-term complications such as atypical femur fracture and jaw osteonecrosis, which are similar to other bisphosphonates.

Reporting side effects and safety updates: Side effects can be reported to the FDA MedWatch program, and up-to-date safety communications are available on the FDA’s website and from the medication guide that comes with the prescription.

Drug and supplement interactions:

• Calcium supplements, antacids, iron, magnesium, and some multivitamins can markedly reduce absorption if taken too close to alendronate; take them at least 30 minutes (often 1–2 hours) after alendronate.
• Other oral medicines taken at the same time (including prescription drugs and OTC products) can interfere with absorption; alendronate should be the first and only medicine taken upon waking.
• Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen may increase the risk of stomach and esophagus irritation when used with alendronate.

Food, drink, and alcohol:

• Food and beverages (including coffee, tea, juice, and mineral water) taken with or shortly after alendronate greatly reduce how much drug your body absorbs.
• Alcohol has no major direct interaction but heavy use can worsen bone loss and increase stomach irritation, so moderation is advised.

Precautions and conditions requiring caution:

• Uncorrected low calcium or vitamin D, serious kidney disease, disorders of the esophagus, or inability to remain upright for 30 minutes make alendronate unsafe or unsuitable.
• People with significant dental disease or who will undergo invasive dental procedures should discuss jaw osteonecrosis risk with their dentist and prescriber before starting or continuing therapy.
• Use caution in patients with active upper GI disease (such as severe reflux, ulcers, or gastritis); closer monitoring or alternative therapy may be needed.

Monitoring needs:

• Blood tests for calcium, vitamin D, and kidney function before and periodically during treatment, especially in higher-risk patients.
• Bone density (DXA) scans typically every 1–2 years to assess response.
• Regular review for new thigh or groin pain, dental problems, or GI symptoms that could signal complications.

Q: How long does it take for alendronate sodium to start working?
A: Bone density may begin to improve within a few months, but fracture-risk reduction is usually assessed over 1–3 years of regular, correctly timed dosing with adequate calcium and vitamin D.

Q: Why do I have to stay upright and avoid food after taking alendronate?
A: Staying upright and waiting at least 30 minutes before eating or taking other medicines helps the tablet pass quickly into the stomach, improves absorption, and reduces the chance of esophagus irritation or ulcers.

Q: How long will I need to stay on alendronate?
A: Many people take it for about 3–5 years before their provider reassesses fracture risk and bone density to decide whether to continue, pause (a “drug holiday”), or switch treatment.

Q: Can I take my calcium or multivitamin with my alendronate dose?
A: No; calcium, antacids, and many supplements block absorption of alendronate and should be taken later in the day, at least 30 minutes to a few hours after your dose.

Q: What should I do if I have stomach pain or trouble swallowing while taking alendronate?
A: Stop further doses and contact your healthcare provider promptly, especially if you have severe chest pain, painful swallowing, or black or bloody stools, as these may indicate serious irritation or damage to the esophagus or stomach.

Storage: Store alendronate sodium tablets or oral solution at room temperature (about 68–77°F / 20–25°C), in a tightly closed container, away from moisture, heat, and direct light, and out of reach of children and pets.

Disposal: Do not use the medication past its expiration date; dispose of unused or expired alendronate in household trash by mixing it with an undesirable substance (such as coffee grounds or cat litter) in a sealed bag or container, unless your pharmacy or community offers a drug take-back program, which is preferred.